Cargando…
Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis
Background: The present study aimed to evaluate the reasons and determinants of BoNT-A discontinuation in patients with stroke, multiple sclerosis, spinal cord injury, and traumatic brain injury. Methods: It is a retrospective study of 56 discontinuer patients treated with botulinum toxin between Ja...
Autores principales: | Cinone, Nicoletta, Santoro, Luigi, Spina, Stefania, Facciorusso, Salvatore, Battaglia, Marco, Baricich, Alessio, Marcogiuseppe, Pasqua, Santamato, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609474/ https://www.ncbi.nlm.nih.gov/pubmed/36287945 http://dx.doi.org/10.3390/toxins14100675 |
Ejemplares similares
-
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach
por: Baricich, Alessio, et al.
Publicado: (2021) -
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
por: Baricich, Alessio, et al.
Publicado: (2023) -
Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report
por: Facciorusso, Salvatore, et al.
Publicado: (2021) -
Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia
por: Smith, Theresa J., et al.
Publicado: (2023) -
Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits
por: Staats, Herman F., et al.
Publicado: (2011)